leisure time -WSS

leisure time

author：explore 2025-09-27 22:48:52 - browse：68812

Terry Horgan pictured at home -- coverage from STAT — Terry Horgan in his family's Montour Falls, N.Y., home, in an undated photo. Kate Collins/The Journal via AP

Last October, a 27-year-old man with Duchenne muscular dystrophy died after receiving a CRISPR-based treatment custom built to treat his particular genetic mutation.

Results of a detailed investigation released on Wednesday suggest that the patient, Terry Horgan, likely died of a previously undocumented adverse effect of the virus used to deliver the CRISPR machinery to his cells.

These viruses, known as adeno-associated viruses, or AAVs, are used in several approved drugs and hundreds of clinical trials to deliver genes into patients, because they are generally benign. But at high doses they can cause side effects and, occasionally, deaths through one of several mechanisms, such as directly injuring the liver or triggering a type of immune response known as complement activation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： There's no autism epidemic. It's an autism diagnosis epidemic

WSS

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

There's no autism epidemic. It's an autism diagnosis epidemic

Supreme Court mifepristone arguments center on docs' right to sue

Hospitals are piloting generative AI tools as regulators play catch

Obamacare plans could cover weight loss drugs

focus

leisure time

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

WATCH: Why do our ears pop?

Psychedelics group wrestles with new pharma identity

Abortion pill case raises question: who can sue the FDA?

In age of alternative facts, a scholarly course on calling out crap

Researchers tackle phage therapy hurdles for wider adoption

United colonoscopy coverage change 'may cost lives,' doctors say

Decaf coffee targeted by food safety group under obscure FDA rule

In age of alternative facts, a scholarly course on calling out crap

FDA's naming rule on biosimilars has undermined competition

explore

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Secretariat’s lessons for human medicine

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Reporting on presidential health from Reagan to Trump and Biden

explore

hotspot

entertainment

hotspot